All In MedTech

Device Trial Radar · NCT07614997

Effectiveness and Safety of the Ulthera® System for Skin Laxity in the Lower Face, Submentum and Neck

Evaluation of the Effectiveness and Safety of the Ulthera® System for Treating Skin Laxity in the Lower Face, Submentum and Neck

Last checked: Nov 20, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingRandomized with 218 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

218

Actual

Start

Jun 15, 2026

Primary completion

Dec 2026

Study completion Mar 2027

Sponsor

Lead sponsor
Merz North America, Inc.Not on our public-company list
Sponsor type
Industry
Collaborators
Ulthera, Inc
First posted
May 29, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 35 years, up to 65 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of this study is to demonstrate superiority of treatment with the Ulthera System compared to untreated control for the improvement of skin laxity of the lower face, submental area and neck and to demonstrate the safety of treatment with the Ulthera System for the improvement of skin laxity of the lower face, submental area and neck.

Conditions

  • Cutis Laxa

Interventions

  • Ulthera SystemDevice

    Participants will receive treatment with the Ulthera system which consists of three primary components: the control unit, handpiece and interchangeable transducers.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proportion of Participants With at Least "Improved" in Lower Face, Submental and Neck Skin Laxity on Global Aesthetic Improvement Scale as Determined by the Blinded Live Evaluator (eGAIS) at Day 90 Compared to Baseline PhotographsTime frame: Day 90

Locations

7 sites in 1 country. Site status is shown where the registry gives one.

  • Merz Investigative Site

    Beijing, Beijing Municipality, China

  • Merz Investigative Site

    Beijing, Beijing Municipality, China

  • Merz Investigative Site

    Guangzhou, Guangdong, China

4 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.